comparative study will be held in between two groups of participants with shatpushpa tail and rajapravartni in the management of alpartava

A clinical comparative study of shatpushpa tail and rajapravartni vati in the management of alpartava - NIL

Status

Recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2026/01/102052

Enrollment

Registered

2026-01-27

Start date

Unknown

Completion date

Unknown

Last updated

2026-06-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N914- Secondary oligomenorrhea

Interventions

Intervention1: Nil: Nil Intervention2: Nil: Nil

Eligibility

Inclusion criteria

Inclusion criteria: Patient age between 18 to 40 years come with complains of alpartava with regular more than two menstrual cycle with menses quantity less than 60ml per cycle

Exclusion criteria

Exclusion criteria: Patient who are suffering from pcod,anemia, tuberculosis,pregnancy, hypothyroidism and age above 40 years

Design outcomes

Primary

Measure	Time frame
Study will be effective in the management of alpartava with rajapravartni vati and shatpushpa tailaTimepoint: Primary outcome will be assessed after 6 month 15 days of study	—

Secondary

Measure	Time frame
Study will be standardized in the mangement of aplartavaTimepoint: Second outcome will be assessed after 2 months of study	—

Countries

India

Contacts

Public ContactDr Trilochan mohanto

Sri sai ayurvedic pg medical college and hospital

tmahanta72@gmail.com9993304678

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Jun 29, 2026